Simplifying Global Compliance
FDA Lays Out Endpoints, Monitoring Requirements for cUTI Trials
Clinical Trials Advisor
FDA is doubling the monitoring period for subjects in trials for antibiotics to treat complicated urinary tract infections.
To View This Article:
Subscribe To Clinical Trials Advisor
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing